Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BAX
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.04 1.48 1.48
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 9.04 16.71 15.32
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.92 16.09 16.57
Cash -5.45 5.96 6.30
Capex 7.55 -0.35 -0.37
Free Cash Flow -96.20 -0.03 0.67
Revenue -7.72 7.07 7.66
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.95 0.38 0.38
Operating Margin 9.14 0.09 0.08
ROA -84.63 < 0.005 < 0.005
ROE -84.47 < 0.005 0.03
ROIC 14.99 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BAX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BAX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BAX is permitted for members.